$QRVO

Feld Peter A sold $133.1M of QRVO (indirect holdings)

Feld Peter A sold 1,328,094 indirectly-held shares of Qorvo, Inc. (QRVO) at $100.25 ($133.15M total) on 2026-06-02.

Original reporting
SEC EDGAR · Feld Peter A
Published Jun 3, 2026, 1:46 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 3, 2026, 2:04 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$QRVO
Neutral
medium confidence
Mentioned
$QRVO
Relevance
7/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$QRVONeutralLow
01

Why it matters

The disclosure may modestly affect short-term sentiment, but it does not introduce new guidance, earnings, deals, or regulatory developments.

02

Market read

Traders may monitor for follow-on insider activity or interpret the sale as a sentiment datapoint, but the event lacks fundamental new information.

03

What to watch

The filing notes no 10b5-1 plan; traders may still treat the sale as more informative, but the article provides no stated reason for the transaction.

Relevance 7/10Novelty 6/10Timing: after the 2026-06-02 insider sale disclosure (filed 2026-06-02)

Background

The article is an SEC Form 4 insider transaction disclosure for Qorvo (QRVO).

Company-level read

Ticker impact

$QRVONeutralMedium confidence
Context

Director Feld Peter A sold 1,328,094 QRVO shares in an open-market transaction worth about $133.1M, per SEC Form 4.

Expected impact

Low near-term impact; any reaction is likely short-lived unless follow-on disclosures emerge.

Evidence & confidence

The filing discloses a large sale size and price, but provides no new company-specific operational or financial information.

Market effects

Limited; this is company-specific insider activity rather than a sector catalyst.

None indicated.

None indicated.

Counterpoint

A large sale can be routine (taxes, diversification) and may not reflect a negative view of fundamentals.

Key entities

  • Qorvo, Inc.

    Subject of the SEC Form 4 insider sale by a director.

  • Feld Peter A

    Director who sold 1,328,094 shares of QRVO on 2026-06-02.

Related articles

$SWKSMedAI 8/10

Skyworks/Qorvo Deal Ahead of Schedule

Skyworks Solutions said it expects to finish its roughly $22B acquisition of Qorvo by year-end, earlier than its prior early-2027 target, after reporting fiscal Q3 results that beat analysts. Skyworks discontinued its 71 cents/share dividend and authorized a $2B buyback. Q3 revenue fell to $935M; analysts expected $926M. The deal values Qorvo at $32.50 cash plus 0.960 Skyworks share per share.

$QRVOMedAI 8/10

Qorvo non-GAAP EPS rises 78% in Q1FY27 on margin expansion

Qorvo reported Q1 FY2027 non-GAAP EPS of $1.64, up 78% year over year and above the $1.10 consensus. Revenue fell 4.15% to $784.8 million, while non-GAAP gross margin rose 880 bps to 52.8%. For FY2027, the company expects non-GAAP diluted EPS above $7.00 and gross margin above 50%, citing margin expansion.

$QRVOMedAI 8/10

Qorvo® Announces Fiscal 2027 First Quarter Financial Results

Qorvo (Nasdaq:QRVO) reported fiscal 2027 first-quarter results ended June 27, 2026. GAAP revenue was $784.8M, gross margin 51.1%, operating income $96.8M, and diluted EPS $0.96. Non-GAAP gross margin was 52.8%, operating income $177.6M, and diluted EPS $1.64. Qorvo said it expects non-GAAP gross margin above 50% and non-GAAP EPS above $7.00 for fiscal 2027, but discontinued conference calls and forward guidance due to its pending Skyworks transaction.

$QRVOMed

Qorvo affirms FY27 adj EPS guidance of $7.00 vs $6.83 est

Qorvo (NASDAQ: QRVO) affirmed its fiscal 2027 adjusted EPS guidance at $7.00, above the $6.83 analyst consensus. The company said it will report fiscal 2027 first-quarter results on July 28, 2026. Due to a pending Skyworks transaction, Qorvo discontinued conference calls and forward-looking guidance.